A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

Clinical trial NCT00241449 · COMPLETED

Trial details

NCT number: NCT00241449
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Metastasis

Start date: 1998-11-01
Primary completion: 2007-03-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.